China Fertility Services Market Size, Share, By Cause of Infertility (Male Infertility and Female Infertility), By Provider (Fertility Clinics, Hospitals, and Others), China Fertility Services Insights, Industry Trend, Forecasts to 2035.
Industry: Healthcare
China Fertility Services Insights Forecasts to 2035
- China Fertility Services Market Size 2024: USD 2.58 Billion
- China Fertility Services Market Size 2035: USD 9.15 Billion
- China Fertility Services Market CAGR 2024: 12.2%
- China Fertility Services Market Segments: Cause of Infertility and Provider
Get more details on this report -
The France fertility services market refers to the industry that provides assisted reproductive treatments through IVF and IUI, and fertility diagnostics, together with related services to help people with infertility and reproductive health needs throughout France.
Alpha IVF Group opened a new office in Guangzhou to expand fertility treatment access and introduce advanced services that include Preimplantation Genetic Testing (PGT-A) and In-Vitro Activation (IVA) for patients.
The government is implementing measures that include childbirth subsidies and childcare support programs, and improved reproductive health services to encourage higher birth rates and strengthen the demand for fertility services.
The France fertility services market will develop through multiple future opportunities, which include expanding fertility preservation services and AI-assisted IVF technologies, rising medical tourism, improved insurance coverage and urban population growth of reproductive health treatment awareness.
Market Dynamics of the China Fertility Services Market:
The China fertility services market is driven by the current fertility treatment systems in the face of multiple challenges that emerge from seven different demographic trends and three specific financial factors.
The China fertility services market is restrained by the system encountering operational difficulties because it faces multiple challenges, which stem from high treatment expenses and insufficient insurance protection.
The future of the China fertility services market is bright and promising, with fertility industry will continue to experience steady growth because AI-based embryo selection systems, fertility preservation methods and private clinics and medical tourism are all developing at a rapid pace.
China Fertility Services Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 2.58 Billion |
| Forecast Period: | 2025-2035 |
| Forecast Period CAGR 2025-2035 : | 12.2% |
| 2035 Value Projection: | USD 9.15 Billion |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 198 |
| Tables, Charts & Figures: | 110 |
| Segments covered: | By Cause of Infertility, By Provider |
| Companies covered:: | Jinxin Fertility Group, CITIC-Xiangya Reproductive & Genetic Hospital, AmCare Women’s & Children’s Hospital, United Family Healthcare, Sichuan Jinxin Xinan Hospital, Shenzhen Zhongshan Urology Hospital, Wuhan Kangjian Foreign-funded Eye & ENT Hospital, Hainan Modern Women and Children’s Hospital, Others |
| Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Market Segmentation
The China fertility services market share is classified into cause of infertility and provider.
By Cause of Infertility:
The China fertility services market is divided by cause of infertility into male infertility and female infertility. Among these, the female infertility segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The increased PCOS diagnosis rate, together with the rise in age-related infertility cases and the higher treatment-seeking behavior of women, creates this situation.
By Provider:
The China fertility services market is divided by provider into fertility clinics, hospitals, and others. Among these, the fertility clinics segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The combination of specialized knowledge and advanced ART technologies, together with dedicated reproductive health services, provides optimal conditions for achieving successful IVF outcomes.
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the China fertility services market, along with a comparative evaluation primarily based on their category offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes category development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Key Companies in China Fertility Services Market:
- Jinxin Fertility Group
- CITIC-Xiangya Reproductive & Genetic Hospital
- AmCare Women's & Children's Hospital
- United Family Healthcare
- Sichuan Jinxin Xinan Hospital
- Shenzhen Zhongshan Urology Hospital
- Wuhan Kangjian Foreign-funded Eye & ENT Hospital
- Hainan Modern Women and Children’s Hospital
- Others
Key Target Audience
- Market Players
- Investors
- End Users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the China, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the China fertility services market based on the below-mentioned segments:
China Fertility Services Market, By Cause of Infertility
- Male Infertility
- Female Infertility
China Fertility Services Market, By Provider
- Fertility Clinics
- Hospitals
- Others
Frequently Asked Questions (FAQ)
-
Q: What is the China fertility services market size?A: China fertility services market is expected to grow from USD 2.58 billion in 2024 to USD 9.15 billion by 2035, growing at a CAGR of 12.2% during the forecast period 2025-2035.
-
Q: What are the key growth drivers of the market?A: the current fertility treatment systems in the face of multiple challenges that emerge from seven different demographic trends and three specific financial factors.
-
Q: What factors restrain the China fertility services market?A: Constraints include the system encountering operational difficulties because it faces multiple challenges, which stem from high treatment expenses and insufficient insurance protection.
-
Q: How is the market segmented by cause of infertility?A: The market is segmented into male infertility and female infertility.
-
Q: Who are the key players in the China fertility services market?A: Key companies include Jinxin Fertility Group, CITIC-Xiangya Reproductive & Genetic Hospital, AmCare Women's & Children's Hospital, United Family Healthcare, Sichuan Jinxin Xinan Hospital, Shenzhen Zhongshan Urology Hospital, Wuhan Kangjian Foreign-funded Eye & ENT Hospital, Hainan Modern Women and Children’s Hospital, and Others.
-
Q: Who are the target audiences for this market report?A: The report targets market players, investors, End Users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).
Need help to buy this report?